These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 10332486

  • 1. CD44 is an independent prognostic factor in conventional renal cell carcinomas.
    Paradis V, Ferlicot S, Ghannam E, Zeimoura L, Blanchet P, Eschwége P, Jardin A, Benoît G, Bedossa P.
    J Urol; 1999 Jun; 161(6):1984-7. PubMed ID: 10332486
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of CD44 molecule in renal cell carcinoma.
    Lucin K, Matusan K, Dordević G, Stipić D.
    Croat Med J; 2004 Dec; 45(6):703-8. PubMed ID: 15578803
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma.
    Yildiz E, Gokce G, Kilicarslan H, Ayan S, Goze OF, Gultekin EY.
    BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of CD44 expression in colorectal carcinomas.
    Sökmen S, Lebe B, Sarioglu S, Füzün M, Terzi C, Küpelioglu A, Ellidokuz H.
    Anticancer Res; 2001 May; 21(6A):4121-6. PubMed ID: 11911305
    [Abstract] [Full Text] [Related]

  • 5. Expression and prognostic value of CD44 isoforms in transitional cell carcinoma of renal pelvis and ureter.
    Masuda M, Takano Y, Iki M, Makiyama K, Noguchi S, Hosaka M.
    J Urol; 1999 Mar; 161(3):805-8; discussion 808-9. PubMed ID: 10022688
    [Abstract] [Full Text] [Related]

  • 6. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
    Hofmockel G, Wittmann A, Dammrich J, Bassukas ID.
    Anticancer Res; 1996 Mar; 16(6B):3807-11. PubMed ID: 9042262
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C, Song C, Hong JH, Kim CS, Ahn H.
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [Abstract] [Full Text] [Related]

  • 8. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN, Mirejovský T, Melinová L, Mandys V.
    Neoplasma; 2000 Aug; 47(6):400-8. PubMed ID: 11263866
    [Abstract] [Full Text] [Related]

  • 9. Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma.
    Matusan K, Dordevic G, Stipic D, Mozetic V, Lucin K.
    J Surg Oncol; 2006 Sep 15; 94(4):325-31. PubMed ID: 16917865
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE, Veys JA, Eskridge MR, Woodruff RD, Hall MC.
    Urol Oncol; 2005 Sep 15; 23(5):328-32. PubMed ID: 16144666
    [Abstract] [Full Text] [Related]

  • 11. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
    Zubac DP, Bostad L, Kihl B, Seidal T, Wentzel-Larsen T, Haukaas SA.
    J Urol; 2009 Nov 15; 182(5):2144-9. PubMed ID: 19758660
    [Abstract] [Full Text] [Related]

  • 12. CD44s and CD44v6 expression in localized T1-T2 conventional renal cell carcinomas.
    Daniel L, Lechevallier E, Giorgi R, Lindner V, De Fromont M, Vieillefond A, Coulange C, Figarella-Branger D.
    J Pathol; 2001 Mar 15; 193(3):345-9. PubMed ID: 11241414
    [Abstract] [Full Text] [Related]

  • 13. Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.
    Fritzsche FR, Oelrich B, Johannsen M, Kristiansen I, Moch H, Jung K, Kristiansen G.
    Clin Cancer Res; 2008 Nov 01; 14(21):7035-42. PubMed ID: 18981000
    [Abstract] [Full Text] [Related]

  • 14. The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma.
    Li JF, Chu YW, Wang GM, Zhu TY, Rong RM, Hou J, Xu M.
    BJU Int; 2009 Feb 01; 103(3):399-405. PubMed ID: 19021626
    [Abstract] [Full Text] [Related]

  • 15. Altered CD44 variant 6 expression in FIGO stage IB cervical carcinoma.
    Ayhan A, Baykal C, Al A, Ayhan A.
    Gynecol Oncol; 2001 Dec 01; 83(3):569-74. PubMed ID: 11733974
    [Abstract] [Full Text] [Related]

  • 16. Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role.
    Miyata Y, Iwata T, Maruta S, Kanda S, Nishikido M, Koga S, Kanetake H.
    Eur Urol; 2007 Sep 01; 52(3):791-7. PubMed ID: 17207914
    [Abstract] [Full Text] [Related]

  • 17. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
    Amin MB, Paner GP, Alvarado-Cabrero I, Young AN, Stricker HJ, Lyles RH, Moch H.
    Am J Surg Pathol; 2008 Dec 01; 32(12):1822-34. PubMed ID: 18813125
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
    Ohno Y, Izumi M, Yoshioka K, Ohori M, Yonou H, Tachibana M.
    Oncol Rep; 2008 Sep 01; 20(3):511-6. PubMed ID: 18695899
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reevaluation of renal cell carcinoma and perirenal fat invasion only.
    Jeon HG, Jeong IG, Kwak C, Kim HH, Lee SE, Lee E.
    J Urol; 2009 Nov 01; 182(5):2137-43. PubMed ID: 19758661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.